CDK4 and nasopharyngeal carcinoma: CDK4 plays key roles in cell proliferation via driving the progression of cells into the DNA synthetic phase of the cell-division cycle [44], and is involved in the pathogenesis and inducing chemotherapy resistance in NPC [45, 46].